Nature Communications (Feb 2018)
Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity
Abstract
Broadly neutralizing antibodies targeting HIV Env could potentially be utilized as therapeutics. Here, Steinhardt et al. engineer a trispecific antibody with specificity for the receptor-binding site, a conserved Env glycan patch and the Env membrane proximal region with nearly pan-isolate neutralization breadth and high potency.